Urology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Maheshwari R et al. - Study concludes that adjuvant chemotherapy does not improve either cancer specific survival (CSS) or overall survival (OS) in high-risk bladder cancer patients.

Methods

Results

Today in Clinical Pharmacology...keeping you current

Long-term Clinical Outcomes of a Phase I Trial of Intravesical Docetaxel in the Management of Non-Muscle-Invasive Bladder Cancer Refractory to Standard Intravesical Therapy
Urology, 12/02/09

High-grade prostate cancer and finasteride
BJU International, 12/02/09

Reboxetine in therapy-resistant enuresis: A retrospective evaluation
Scandinavian Journal of Urology and Nephrology, 12/01/09